The multivitamin is the most-taken supplement in the world, a daily blend of a dozen or more vitamins and minerals at roughly the amounts a body needs. It is inexpensive, it has a long safety record at normal doses, and for people with a specific dietary gap it is useful insurance. Where it falls short of its reputation is disease prevention: in well-nourished adults, the large trials have mostly not found that a daily multivitamin prevents cancer, heart disease, or early death.
A newer line of research points to a small memory benefit in older adults, which recent trials are still working to confirm. Here is what a multivitamin does, what the big trials changed, how to think food-first, who benefits, the Chinese medicine framing, and the few situations that call for care.
Findings & Outcomes
What It Is
A multivitamin is a broad, low-dose blend, usually a dozen or more vitamins and minerals at around the amounts a body needs in a day. The idea behind it is simple insurance: cover the small gaps a diet might leave, so no single nutrient runs short. That logic holds where a gap exists. The large trials of the last two decades tested the bigger claim: that topping up an already well-fed person prevents cancer, heart disease and early death. There the results have mostly shown no benefit.
Anatomy of the Practice
1A broad, low-dose blend
A typical multivitamin carries a dozen or more vitamins and minerals, each at roughly the daily requirement rather than a megadose. It is built to fill gaps across the board, not to deliver a large therapeutic dose of any one nutrient. This low-dose, wide-coverage design is what separates an ordinary multivitamin from the high-dose single-nutrient supplements that have caused harm in some trials.
2Nutrients work as cofactors
Vitamins and minerals are the parts your enzymes, blood, bones and nerves are built and run on. When intake of one falls short, the processes that depend on it falter, and restoring it fixes the shortfall. The catch is a threshold: once a level is adequate, adding more does not keep improving the process, because the body stores or excretes the excess.
3Value tracks the size of the gap
Where a gap exists, from a restricted diet, malabsorption, pregnancy, limited sun, or older age, filling it restores function and can prevent disease. Where intake is already adequate, there is no deficit to correct, which is why the clearest benefits of supplementation show up in people who were short of something, and why the well-fed see little.
How It Works
The mechanism is correction of a shortfall. Each vitamin and mineral is a cofactor the body uses to build tissue, carry oxygen, clot blood, fire nerves and run metabolism, and a deficiency stalls whatever depends on it. Supply the missing nutrient and the process resumes, which is why a deficiency responds so clearly to repletion.
The multivitamin's reputation rests on a further assumption: that if a little is essential, more must be protective. Nutrient status follows a threshold: below adequacy, adding the nutrient helps a great deal; at or above adequacy, adding more does little, because the surplus is stored or passed out. A multivitamin is most useful to the person who has a gap to fill, and closest to inert in the person whose diet already covers the requirement. For the diet that supplies most of what a multivitamin covers, and a single nutrient with the same gap between reputation and trial result, see whole foods and vitamin D.
What Changed
For a long time the received message was that everyone should take a daily multivitamin for health and long life, a small insurance policy no one could regret. It was reasonable to believe. Observational studies showed that people who took supplements tended to be healthier. But people who take a daily multivitamin also tend to exercise more, eat better and see a doctor sooner, so that link reflects the healthier habits around the pill more than the pill itself. It also made intuitive sense that covering every nutrient would prevent disease. Then the large randomized trials reported, and the benefit for well-nourished people mostly disappeared.
The Physicians' Health Study II followed 14,641 men for more than a decade. A daily multivitamin produced a modest, borderline reduction in total cancer, with a confidence interval that nearly reached no effect, and it did nothing measurable for heart attack, stroke or cardiovascular death. The 2022 review behind the US Preventive Services Task Force assessment pooled 84 studies in more than 700,000 people and reached the same place: little to no benefit for preventing cancer, cardiovascular disease or death in the general adult population. Both drew on a population that was already reasonably nourished, and in that setting a broad low-dose supplement had little left to correct.
The value did not vanish. It was always in filling specific gaps: a vegan short of B12, someone whose gut absorbs poorly, a person planning a pregnancy who needs folate, an older adult who makes and absorbs less. A newer line of research adds a question. Two recent trials, COSMOS-Mind and COSMOS-Web, found a small improvement in memory and global cognition in older adults on a daily multivitamin, a signal an earlier trial in male physicians did not see. It is early, it is being studied further, and it belongs in the emerging column.
A daily multivitamin is not a longevity intervention for the well-fed. It fills a gap where one exists, and the cognition question is still open.
Ways to Do It
The whole approach is food-first. A varied diet covers the nutrients most people need, so the only thing to work out is whether you are in a group with a gap to fill; which multivitamin you buy barely matters. If you are in such a group, a basic low-dose product is sensible insurance, and if you are pregnant or planning to be, folate is the one clearly proven case.
A varied whole-food diet, plenty of vegetables and fruit, legumes, whole grains, and some fish, eggs or lean meat, supplies the vitamins and minerals most people need, in a food matrix a pill cannot copy. This is the foundation, and for a person eating this way most of the time, a multivitamin has little gap left to fill. Start here before reaching for a supplement.
The value of a multivitamin is for specific situations. A vegan or strict vegetarian diet runs short on B12 and sometimes iron and zinc. Malabsorption conditions such as celiac disease, inflammatory bowel disease, or a history of bariatric surgery reduce uptake across the board. Older adults absorb and make less B12 and vitamin D. Very limited sun exposure lowers vitamin D. If one of these fits you, filling the gap is where a supplement earns its place.
This is the one clearly proven prevention benefit. Folic acid taken around the time of conception sharply reduces the risk of neural tube defects such as spina bifida, which is why a prenatal supplement or a folate-containing multivitamin is standard advice for anyone who may become pregnant. Here the gap is specific, the timing is early (before and in the first weeks of pregnancy), and the evidence is strong.
For someone who wants the cover without a specific deficiency, a basic generic multivitamin at around daily-requirement amounts is a reasonable, inexpensive choice, and there is no need for a premium formula or megadoses. Two practical points: men and postmenopausal women rarely need added iron and can pick an iron-free formula, and anyone who smokes should avoid standalone high-dose beta-carotene. An ordinary low-dose multivitamin is a different thing from the high-dose single-nutrient supplements that caused harm in the smoking trials.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Fertility
Folic acid around conception cut neural tube defects 72% in high-risk women (MRC)
Taking folic acid around the time of conception sharply reduced the risk of neural tube defects such as spina bifida in women who had already had an affected pregnancy, by about 72 percent. This is the clearest case where a supplement, filling a specific gap at a specific time, prevents disease.
The Medical Research Council Vitamin Study randomized 1817 women at high risk of a neural tube defect pregnancy (because of a previous affected pregnancy) across 33 centers in seven countries to folic acid, other vitamins, both, or neither, around the time of conception. Among 1195 completed pregnancies with a known outcome, folic acid produced a 72% protective effect against neural tube defect recurrence (relative risk 0.28, 95% CI 0.12 to 0.71). The other vitamins showed no significant effect (RR 0.80). This trial is the basis for the standing recommendation that women who may become pregnant get adequate folic acid, and it anchors the principle that supplementation delivers when it fills a well-defined gap.
The study · 1
Heart And Vascular
A daily multivitamin did not lower cardiovascular events or deaths in men over 11 years (PHS II)
In the same large trial of male physicians, a daily multivitamin made no measurable difference to heart attacks, strokes, cardiovascular deaths, or deaths from any cause over more than a decade.
In the cardiovascular arm of the Physicians' Health Study II (14,641 men, median 11.2 years), a daily multivitamin had no significant effect on major cardiovascular events (11.0 vs 10.8 events per 1000 person-years; HR 1.01, 95% CI 0.91 to 1.10, P=0.91). It also did nothing for total myocardial infarction (HR 0.93), total stroke (HR 1.06), or cardiovascular mortality (HR 0.95), and was not significantly associated with total mortality (HR 0.94, 95% CI 0.88 to 1.02, P=0.13). The result speaks to a well-nourished population, where a broad low-dose supplement had little cardiovascular process left to change.
Who this may not transfer to:Men only; a clean null for cardiovascular events in men, and while there is no strong reason to expect a benefit in women that the trials missed, the finding was not measured in women here.
The study · 1
Sesso 2012, JAMA (Physicians' Health Study II, cardiovascular) · JAMA
Cancer Risk And Outcome
A low-dose antioxidant blend did not cut cancer, heart disease or death overall, only cancer in men (SU.VI.MAX)
A French trial of a low-dose antioxidant vitamin-and-mineral blend found no overall benefit for cancer, heart disease or death, but when split by sex it lowered cancer in men and not in women, likely because the men started with lower nutrient levels.
The SU.VI.MAX trial randomized roughly 13,000 French adults to a daily low-dose combination of antioxidant vitamins and minerals (vitamin C, vitamin E, beta-carotene, selenium, zinc) or placebo for 7.5 years. Overall there were no significant differences in total cancer (4.1% vs 4.5%), ischemic cardiovascular disease (2.1% vs 2.1%) or all-cause mortality. A significant sex interaction emerged for cancer (P=0.004): a protective effect in men (RR 0.69, 95% CI 0.53 to 0.91) but none in women (RR 1.04, 95% CI 0.85 to 1.29). The authors attributed the male-only benefit to men's lower baseline antioxidant status, especially beta-carotene, which fits the theme that supplementation helps most where a gap exists.
The study · 1
Hercberg 2004, Arch Intern Med (SU.VI.MAX) · Arch Intern Med
A daily multivitamin lowered total cancer about 8% in older men (PHS II)
In a large trial of male physicians, taking a daily multivitamin for over a decade led to a small drop in the overall rate of cancer, about 8 percent. The effect was modest and borderline, and it did not change deaths from cancer.
The Physicians' Health Study II randomized 14,641 male US physicians aged 50 and over (mean 64) to a daily common multivitamin or placebo, with treatment and follow-up over a median 11.2 years. Men on the multivitamin had a statistically significant reduction in total cancer (17.0 vs 18.3 events per 1000 person-years; HR 0.92, 95% CI 0.86 to 0.998, P=0.04). The upper bound of the interval almost touched 1.0, so the finding is modest and fragile. There was no significant effect on prostate cancer (HR 0.98), colorectal cancer (HR 0.89), or cancer mortality (HR 0.88, P=0.07). This is the one large multivitamin trial to report a total-cancer signal.
Who this may not transfer to:The trial enrolled only men; whether the same modest cancer effect holds in women was not tested here, and a separate French antioxidant trial (SU.VI.MAX) found a cancer benefit in men but not women, so the signal should not be assumed to transfer.
The study · 1
Gaziano 2012, JAMA (Physicians' Health Study II, cancer) · JAMA
Cognition
A daily multivitamin gave older men no memory or thinking benefit over a decade (PHS II)
An earlier trial in older male physicians found that long-term daily multivitamin use gave no measurable benefit to memory or overall thinking, which is why the newer cognition signal is treated as emerging rather than settled.
A cognitive substudy of the Physicians' Health Study II assessed 5947 male physicians aged 65 and over with repeated telephone cognitive testing over roughly a decade of multivitamin or placebo use. There was no difference between groups in cognitive change over time or in the level of cognition at any assessment. For the global composite, the mean difference in change was -0.01 standardized units (95% CI -0.04 to 0.02), and verbal memory was likewise unchanged. The authors noted the doses may have been too low, or the population too well-nourished, to benefit. This null in men predates and sits against the later COSMOS signals in older adults.
Who this may not transfer to:Men only; the later COSMOS trials that found a benefit enrolled mostly women, so this null in men and the newer positive signal in a mixed, majority-female sample are not directly comparable, and neither settles the other.
The study · 1
Grodstein 2013, Ann Intern Med (Physicians' Health Study II, cognition) · Ann Intern Med
A daily multivitamin slightly improved global cognition over 3 years in older adults (COSMOS-Mind)
In older adults, a daily multivitamin produced a small but statistically significant improvement in overall thinking and memory over three years compared with placebo, in a trial that was mainly designed to test cocoa extract.
COSMOS-Mind, a 3-year randomized two-by-two factorial trial in 2262 older adults (mean age 73, 60% women), tested cocoa extract and a commercial multivitamin-mineral against placebo, with global cognition by telephone as an outcome. Cocoa extract had no effect (z=0.03, P=0.28), but the multivitamin significantly improved global cognition (mean z=0.07, 95% CI 0.02 to 0.12, P=0.007), with additional benefits for memory and executive function. The effect was most pronounced in participants with a cardiovascular history. This is one of the first randomized signals that a multivitamin may aid cognition in older age, and it is a secondary rather than primary endpoint of the trial.
The study · 1
Baker 2023, Alzheimers Dement (COSMOS-Mind) · Alzheimers Dement
A daily multivitamin improved memory in older adults, worth about 3.1 years (COSMOS-Web)
In a large web-based trial, older adults taking a daily multivitamin remembered a word list better than those on placebo. The improvement was estimated to be worth about three years of age-related memory change, though it did not extend to other thinking tests.
COSMOS-Web randomized older adults (analysis n around 3560) to a daily multivitamin or placebo and measured memory with an online recall task. The multivitamin group had significantly better immediate recall at 1 year, the primary endpoint (P=0.025), and across the 3 years on average (P=0.011). Using the cross-sectional relationship between age and recall, the authors estimated the effect equated to about 3.1 years of age-related memory change. There were no significant effects on the secondary cognitive outcomes. Together with COSMOS-Mind, it forms an emerging body of evidence for a modest cognitive benefit in older adults, concentrated in memory.
The study · 1
Yeung 2023, Am J Clin Nutr (COSMOS-Web) · Am J Clin Nutr
Longevity And Mortality
Across 84 studies in 739,803 adults, supplements did little to prevent cancer, heart disease or death (USPSTF)
The large review behind the 2022 US Preventive Services Task Force assessment pooled 84 studies in more than 700,000 people and found that supplements do little or nothing to prevent cancer, heart disease or early death in the general adult population, aside from a small and uncertain cancer signal for multivitamins.
The evidence review commissioned by the US Preventive Services Task Force (O'Connor 2022) synthesized 84 studies in 739,803 community-dwelling, non-pregnant adults. In pooled analyzes, multivitamin use was associated with slightly lower incidence of any cancer (OR 0.93, 95% CI 0.87 to 0.99; 4 RCTs) and lung cancer (OR 0.75; 2 RCTs), but the review flagged important limitations in that evidence. Vitamin D and vitamin E showed no significant effect on all-cause mortality, cardiovascular disease or cancer. The Task Force concluded with moderate certainty that supplementation confers little or no net benefit for preventing cardiovascular disease, cancer or death in the general adult population, and issued an insufficient-evidence statement for multivitamins.
The studies · 2
Older women taking multivitamins had a 2.4% higher death rate, an observational link that cannot show cause
In a long-running study following older women, those who used multivitamins had a slightly higher death rate than those who did not. Because this is an observational study, it cannot show that the supplements caused the difference.
The Iowa Women's Health Study followed 38,772 older women (mean age 62 at baseline) with repeated self-reported supplement use from 1986 through 2008 (about two decades). In multivariable-adjusted models, multivitamin use was associated with a small increase in total mortality (HR 1.06, 95% CI 1.02 to 1.10; absolute risk increase 2.4%), with a stronger association for supplemental iron (HR 1.10, rising with dose) and an inverse association for calcium (HR 0.91). The associations are small, and observational: they cannot establish cause. It is a data point that routine supplement use in older women showed no survival advantage, and if anything a slight adverse association, rather than proof of harm.
Who this may not transfer to:Women only; whether a similar mortality association appears in men was not studied here, and the randomized trials in men (Physicians' Health Study II) found no effect on total mortality either way.
The study · 1
Mursu 2011, Arch Intern Med (Iowa Women's Health Study) · Arch Intern Med
Go Deeper
- Whole foods: the varied diet that supplies most of what a multivitamin is meant to cover, in a form a pill cannot copy.
- Vitamin D: a single nutrient with the same lesson, where correcting a shortfall helps and routine high-dose topping-up does not.
- Omega-3 fish oil: another popular supplement tested in the same large trials, with its own gap between reputation and result.
The Chinese Medicine View
The multivitamin is a modern invention, a concentrate of isolated nutrients that did not exist when the classical Chinese pharmacopoeia was written, so there is no traditional entry for it, no channel it enters, no flavor or temperature assigned by any historical text. The tradition offers a way to place it, as a lens, not as evidence.
The relevant idea is the Spleen. In Chinese medicine the Spleen governs digestion in the broadest sense: it transforms food and drink into the Qi and Blood the body is built and run on. Good nourishment, in this view, is a working digestion turning whole food into usable vitality, which lines up closely with the modern finding that nutrients do their work best inside whole meals and that a well-fed person gains little from a supplement. The two frameworks meet at the food-first instinct: the tradition would look first to the diet and the strength of digestion, and treat a concentrated supplement as a way to cover a specific shortfall rather than as a source of vitality in itself.
A practitioner would not call a multivitamin a Spleen tonic in any classical sense, and the mapping does not make it a Chinese herb or a substitute for one. It is a way for a reader who thinks in this framework to see where a modern supplement's effects sit relative to a concept the tradition has reasoned about for a long time.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
High-dose beta-carotene raised lung cancer 18% in male smokers (ATBC)
The Alpha-Tocopherol, Beta Carotene (ATBC) Cancer Prevention Study randomized 29,133 male smokers aged 50 to 69 in Finland to beta-carotene (20 mg/day), vitamin E, both, or placebo, for 5 to 8 years. Unexpectedly, men receiving beta-carotene had an 18% higher incidence of lung cancer (95% CI 3% to 36%) and 8% higher total mortality (95% CI 1% to 16%), driven by more deaths from lung cancer and ischemic heart disease. Vitamin E showed no benefit for lung cancer. The dose was far above what a standard multivitamin contains, and the harm was specific to smokers, but it established that a single antioxidant at high dose can do harm where it was expected to protect.ATBC Study Group 1994, N Engl J Med
Beta-carotene plus vitamin A raised lung cancer 28% in smokers and asbestos workers (CARET)
The Beta-Carotene and Retinol Efficacy Trial (CARET) randomized 18,314 smokers, former smokers and asbestos-exposed workers to beta-carotene (30 mg/day) plus vitamin A (retinyl palmitate) or placebo. After a mean 4 years, the active group had a relative risk of lung cancer of 1.28 (95% CI 1.04 to 1.57, P=0.02), death from any cause of 1.17 (95% CI 1.03 to 1.33), and death from lung cancer of 1.46 (95% CI 1.07 to 2.00). The trial was stopped 21 months early. CARET replicated the ATBC finding in a mixed-sex, high-risk population, cementing that high-dose beta-carotene is harmful in people at elevated lung cancer risk.Omenn 1996, N Engl J Med (CARET)
It is not a substitute for food
A multivitamin supplies isolated vitamins and minerals, not the fiber, the phytochemicals, or the whole-food matrix that a varied diet provides and that a good deal of the health benefit of eating well seems to depend on. It is sensible insurance against a specific gap, not a replacement for meals, and it should not become a reason to eat less well. Build the diet first and let the supplement cover what the diet leaves short.
Avoid standalone high-dose beta-carotene if you smoke
The harm signal in the research is specific to large doses of single antioxidants, above all beta-carotene, in people who smoke or have heavy asbestos exposure. This is a different product from an ordinary low-dose multivitamin, and the practical takeaway is to avoid separate high-dose beta-carotene or vitamin A supplements if you are a current or former smoker. The cited trials below spell out the size of the risk.
Iron and the fat-soluble upper limits
Men and postmenopausal women rarely need supplemental iron, absorb it efficiently, and can gradually accumulate it, so an iron-free multivitamin is usually the better choice for them unless a clinician has identified a need. The fat-soluble vitamins A and, in large amounts, D can build up in the body, so keep to at or near daily-requirement doses rather than stacking a multivitamin on top of separate high-dose single-nutrient pills.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Should everyone take a daily multivitamin?
For a well-nourished person, the case is weak. The large trials of routine multivitamin use in generally healthy adults have mostly not found that it prevents cancer, heart disease or early death, so a blanket daily habit for everyone is not well supported. Where a multivitamin does earn its place is filling a specific gap: a vegan short of B12, someone with a malabsorption condition, a person planning a pregnancy, an older adult, or anyone with very limited sun. If none of those fit and you eat a varied diet, the expected benefit is small.
Do multivitamins prevent cancer or heart disease?
Mostly no, in people who are already nourished. The Physicians' Health Study II found a modest, borderline reduction in total cancer in men and no effect on cardiovascular events, and the large 2022 review behind the US Preventive Services Task Force assessment, pooling more than 700,000 people, found little to no benefit for preventing cancer, heart disease or death in the general adult population. The one consistent exception is that correcting a diagnosed deficiency, rather than topping up someone who already has enough, is a different situation.
Can a multivitamin improve memory?
There is an emerging signal. Two recent trials, COSMOS-Mind and COSMOS-Web, found a small improvement in memory and global cognition in older adults taking a daily multivitamin, with COSMOS-Web estimating a benefit equivalent to about 3.1 years of age-related memory change. This is new, it is being studied further, and an earlier trial in older male physicians found no cognitive benefit, so it is best treated as a promising early finding.
Who benefits from a multivitamin?
People with a specific gap. That includes vegans and strict vegetarians (B12, sometimes iron and zinc), people with malabsorption conditions such as celiac disease, inflammatory bowel disease or a history of bariatric surgery, anyone planning or in early pregnancy (folate), many older adults (B12 and vitamin D), and people with very limited sun exposure. For these groups a multivitamin, or a targeted supplement, restores something the body is short of, which is where the benefit shows.
Are multivitamins safe?
At normal daily-requirement doses, an ordinary multivitamin has a long record of safety. The cautions are specific: it is not a substitute for eating well, standalone high-dose beta-carotene raised lung cancer risk in smokers in two large trials, and men and postmenopausal women usually do not need the iron some formulas contain. The full detail and the situations that call for care are gathered in the Cautions above.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 12 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.